This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial.
JAMA Internal Medicine:2021: December 13 Full text
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry.
Heart:2021: October 5 Full text
Clinical Practice
Impact of the COVID-19 pandemic on hospital admissions of nursing home residents.
Australasian Journal on Ageing:2021: December 15 Full text
COVID-19 and geriatric medicine in Australia and New Zealand. AUS
Australasian Journal on Ageing:2021: December 13 Full text
Assessment of a hotel-based protective housing program for incidence of SARS-CoV-2 infection and management of chronic illness among persons experiencing homelessness.
JAMA Network Open:2021: December 13 Full text
Diagnosis
MRI and CT coronary angiography in survivors of COVID-19.
Heart:2021: December 10 Full text
Infection Control
Clinical accuracy and agreement between tympanic and forehead body temperature measurements for screening of patients with COVID-19.
Journal of Clinical Nursing:2021: December 15 Full text
Pathophysiology and Epidemiology
Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis.
JAMA Network OPen:2021: December 14 Full text
The incubation period distribution of coronavirus disease 2019: a systematic review and meta-analysis.
Clinical Infectious Diseases:2021:73(12):2344-52 Full text
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.
Thorax:2021: December 16 Full text
Long Covid
Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study.
BMJ Open Respiratory Research:2021: December 9 Full text
Vaccines
Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients.
MedRxiv:2021:2021: December 21 Full text
Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
Clinical Infectious Diseases:2021: December 16 Full text
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
BMJ:2021: November 25 Full text
A Single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
Cell Reports Medicine:2021: December 14 Full text
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
BMJ:2021: November 25 Full text
Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study.
BMJ:2021: December 15 Full text
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
Lancet:2021: December 20 Full text
Humoral responses after SARS-CoV-2 mRNA vaccination and breakthrough infection in cancer patients.
Mayo Clinical Proceedings: Innovations, Quality and Outcomes:2021: December 13 Full text
Vaccine Adverse Effects
Newly diagnosed IgA nephropathy with gross haematuria following COVID-19 vaccination.
QJM:2021: December 1 Full text
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
BMJ:2021: December 16 Full text
Immunology
Antibody response and variant cross-neutralization after SARS-CoV-2 breakthrough infection.
JAMA:2021: December 16 Full text
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
Cell Reports:2021: December 7 Full text
Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response.
Cell Host and Microbe:2021: December 7 Full text
